The Trump docket …
The U.S. Supreme Court set April 25 as the date it will hear Trump’s immunity claim in the 2020 election case … U.S. prosecutors accused Trump of bringing a “frivolous” claim of presidential immunity in the classified documents case … Trump emerged victorious in the Colorado ballot disqualification case at the Supreme Court … Lawyers for Trump asked a court to reject a prosecution request for a gag order at his criminal trial over hush money paid to porn star Stormy Daniels … Here is a timeline on how Trump’s trial dates overlap with his 2024 election campaign.
Musk v. OpenAI …
Elon Musk sued OpenAI and its CEO, Sam Altman, saying they abandoned the startup’s original mission to develop AI for the benefit of humanity and not for profit … OpenAI hit back at Musk’s claims with emails that showed the billionaire supported its plan to create a for-profit entity and pushed for a merger with Tesla … Reuters columnist Lauren Silva Laughlin writes how Musk vs. Altman is a battle everyone loses.
Diversity & Inclusion …
U.S. District Judge Mark Pittman in Texas barred a federal minority-business agency from turning away applicants based on race … The 2nd circuit upheld the dismissal of the conservative group Do No Harm’s challenge to Pfizer’s diversity initiatives … The 11th Circuit upheld a lower court’s ban on Florida’s ‘woke’ workplace training law, saying it violates employers’ constitutional free speech rights … SCOTUS sidestepped a conservative group’s challenge to Virginia Tech University’s policy for monitoring and reporting allegations of bias … A female production coordinator at SpaceX sued the company, claiming she was paid less than male colleagues and that company officials retaliated against her for reporting sexual harassment … A North Dakota U.S. judge ruled the Christian Employers Alliance do not have to offer health insurance coverage to employees for gender transition treatments.
|
A 2nd Circuit decision on Wednesday that upheld the dismissal of a conservative group’s challenge to a Pfizer program to boost diversity raised a tough question: When an organization brings a lawsuit claiming harm to its members, must those members be identified by name? That question, writes Alison Frankel, divided the panel that heard the Pfizer case — and has arguably divided the federal circuits. Read more.
Check out other recent pieces from our columnists: Alison Frankel and Jenna Greene
|
Additional writing by Kuheli Biswas.
|